State Board of Administration of Florida Retirement System
GEVA

State Board of Administration of Florida Retirement System’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-17,620
Closed -$1.72M – 2501
2015
Q1 		$1.72M Buy
17,620
+230
+1% +$24.4K 0.01% 1217
2014
Q4 		$1.61M Buy
17,390
+381
+2% +$30.1K 0.01% 1268
2014
Q3 		$1.17M Buy
17,009
+310
+2% +$22.2K ﹤0.01% 1438
2014
Q2 		$1.75M Buy
16,699
+3,481
+26% +$296K 0.01% 1241
2014
Q1 		$1.1M Buy
13,218
+1,960
+17% +$181K ﹤0.01% 1514
2013
Q4 		$729K Hold
11,258
– – ﹤0.01% 1808
2013
Q3 		$713K Hold
11,258
– – ﹤0.01% 1798
2013
Q2 		$473K Buy
+11,258
New +$513K ﹤0.01% 2013

State Board of Administration of Florida Retirement System's GEVA Position: Q2 2015 in Review

State Board of Administration of Florida Retirement System sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 17,620 shares — an estimated $1.72M sold.

State Board of Administration of Florida Retirement System first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $1.75M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • State Board of Administration of Florida Retirement System reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 17,620 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $1.72M.
  • State Board of Administration of Florida Retirement System first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • State Board of Administration of Florida Retirement System's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.75M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2015, filed 29 Jul 2015.